4,364 research outputs found

    Health considerations for transgender women and remaining unknowns : a narrative review

    Get PDF
    Transgender (trans) women (TW) were assigned male at birth but have a female gender identity or gender expression. The literature on management and health outcomes of TW has grown recently with more publication of research. This has coincided with increasing awareness of gender diversity as communities around the world identify and address health disparities among trans people. In this narrative review, we aim to comprehensively summarize health considerations for TW and identify TW-related research areas that will provide answers to remaining unknowns surrounding TW's health. We cover up-to-date information on: (1) feminizing gender-affirming hormone therapy (GAHT); (2) benefits associated with GAHT, particularly quality of life, mental health, breast development and bone health; (3) potential risks associated with GAHT, including cardiovascular disease and infertility; and (4) other health considerations like HIV/AIDS, breast cancer, other tumours, voice therapy, dermatology, the brain and cognition, and aging. Although equally deserving of mention, feminizing gender-affirming surgery, paediatric and adolescent populations, and gender nonbinary individuals are beyond the scope of this review. While much of the data we discuss come from Europe, the creation of a United States transgender cohort has already contributed important retrospective data that are also summarized here. Much remains to be determined regarding health considerations for TW. Patients and providers will benefit from larger and longer prospective studies involving TW, particularly regarding the effects of aging, race and ethnicity, type of hormonal treatment (e.g. different oestrogens, anti-androgens) and routes of administration (e.g. oral, parenteral, transdermal) on all the topics we address

    Healthcare Access and Utilization by Transgender Populations: A United States Transgender Survey Study

    Full text link
    Transgender communities in the United States are highly marginalized and have been systematically and infrastructurally ignored due to the widespread fundamental belief that gender exists as a binary classification. The dichotomous theoretical framework of sex and gender prevented public recognition of this community as a population of interest for public health research and targeted intervention. Sexual and gender minority (SGM) populations have fought for basic human rights, including access to affordable healthcare. The National Center for Transgender Equality (NCTE) was founded in 2003 to advocate for the advancement of equality for transgender people. In 2015, the NCTE conducted the United States Transgender Survey (USTS) to collect data on people who identify on the transgender spectrum (n=27,715). For this research, data from the USTS respondents were segmented into two general populations, “binary” and “non-binary”. The “binary” population was further segmented into broad categories: trans-femme/trans-feminine (TF), trans-masc/trans-masculine (TM). The “nonbinary” (NB) category encompassed gender non-conforming (GNC) identities and individuals who did not adhere to binary identifiers. The purpose of this study was to elucidate health disparities regarding access to and utilization of healthcare in the transgender community to determine the need for policy changes and public health interventions. Additionally, an analysis was conducted to determine the relationships between identity and terminology for the purpose of assessing the feasibility of data collection for sexual orientation and gender identity (SOGI) in government surveys based on self-reported data. USTS data reported disparities in access to healthcare within gender identity categories, and TM and TF were more likely to report postponement of healthcare utilization due to fear of discrimination than NB respondents. NB respondents were significantly less likely to desire access to transgender specific care, but they were likely to identify with the term transgender. Participants from all gender identity categories were likely to answer SOGI questions on a national survey if asked. This research adds to the growing body of knowledge concerning inclusion of SOGI questions on population surveys. Results from this USTS analysis indicate the need for further research on the intersectional and diverse population of SGM to classify health disparities and to work towards solutions for health equity for transgender people

    Factors Associated with PrEP and PEP Uptake Among the LatinX Population

    Get PDF
    Advanced Undergraduate Winner Uptake of PrEP and PEP amongst LatinX population has been low, despite being a population disproportionately affected by HIV. Systemic barriers and cultural factors affect general LatinX approaches to healthcare and may impact uptake of these medications. The purpose of this study is to assess the factors that are associated with the likelihood to take PrEP and PEP in the LatinX population. In this cross-sectional study, survey data was collected from 169 LatinXs from January - March 2020. Using the Sexual Health Model as the theoretical framework, the survey examined the following four constructs to identify factors associated with PrEP and PEP uptake: talking about sex, culture and sexual identity, sexual health care and safer sex, and spirituality. Descriptive statistics, chi-square tests, correlations, and logistic regressions were calculated. The likelihood to take PrEP ( p \u3c 0.001) significantly predicted the likelihood of taking PrEP if it were free, as did the likelihood to take PEP (p \u3c 0.001) to the likelihood of taking PEP if it were free. While sexual comfort was not a predictor of the likelihood of taking PrEP or PEP, it had a significant positive correlation with the likelihood of uptake for both. The factors HIV knowledge, HIV/STI-related behaviors, Machismo beliefs, and folk illness beliefs were not statistically significant. The findings contribute to the literature regarding the barriers of PrEP and PEP uptake among LatinXs. The results suggest that LatinXs must become better informed of these prevention strategies and lessen possible worries regarding drug expenses and side-effects
    corecore